CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
Diabetes Metab J. 2015;39(3):247-252.   Published online April 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.3.247

Excel Download

Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J2015;39:247-52)
Diabetes & Metabolism Journal. 2015;39(4):348   Crossref logo
Link1 Link2 Link3

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
Diabetes & Metabolism Journal. 2015;39(3):247   Crossref logo
Link1 Link2 Link3

Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J2015;39:247-52)
Diabetes & Metabolism Journal. 2015;39(4):350   Crossref logo
Link1 Link2 Link3

Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
Vascular Health and Risk Management. 2015;417   Crossref logo
Link1

Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure? ∗
JACC: Heart Failure. 2014;2(6):583-585   Crossref logo
Link1 Link2

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
Cardiovascular Diabetology. 2018;17(1):   Crossref logo
Link1 Link2 Link3

Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk
Journal of Cardiology. 2019;73(1):28-32   Crossref logo
Link1 Link2

Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?
Current Cardiovascular Risk Reports. 2015;9(8):   Crossref logo
Link1 Link2 Link3

Assessment of the Risk of Hospitalization for Heart Failure With Dipeptidyl Peptidase-4 Inhibitors, Saxagliptin, Alogliptin, and Sitagliptin in Patients With Type 2 Diabetes, Using an Alternative Measure to the Hazard Ratio
Annals of Pharmacotherapy. 2017;51(7):570-576   Crossref logo
Link1 Link2 Link3

Heart failure and dipeptidyl peptidase-4 inhibitors
European Journal of Heart Failure. 2014;16(6):603-607   Crossref logo
Link1 Link2